
The Library
Beta interferons and glatiramer acetate for treating multiple sclerosis
Tools
NICE Project Team and Appraisal Committee Members (Including: Armoiry, Xavier, Auguste, Peter and Clarke, Aileen). (2018) Beta interferons and glatiramer acetate for treating multiple sclerosis. National Institute for Health and Care Excellence.
![]() |
PDF
WRAP-beta-interferons-and-glatiramer-acetate-for-treating-multiple-sclerosis-NICE-2018.pdf - Published Version Embargoed item. Restricted access to Repository staff only - Requires a PDF viewer. Available under License Available under NICE UK Open Content Licence. Download (161Kb) |
![]() |
PDF (Licence Statement)
NICE-UK-Open-Content-Licence-06-08-2018.pdf - Permissions Correspondence Embargoed item. Restricted access to Repository staff only - Requires a PDF viewer. Download (63Kb) |
Official URL: https://www.nice.org.uk/guidance/ta527
Abstract
Evidence-based recommendations on beta interferons (Avonex, Betaferon, Extavia, Rebif) and glatiramer acetate (Copaxone) for treating multiple sclerosis in adults.
This guidance replaces NICE technology appraisal guidance 32 on beta interferon and glatiramer acetate for the treatment of multiple sclerosis.
Item Type: | Report | |||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Divisions: | Faculty of Science, Engineering and Medicine > Medicine > Warwick Medical School > Health Sciences Faculty of Science, Engineering and Medicine > Medicine > Warwick Medical School |
|||||||||||||||
Publisher: | National Institute for Health and Care Excellence | |||||||||||||||
ISBN: | 9781473129825 | |||||||||||||||
Official Date: | 27 June 2018 | |||||||||||||||
Dates: |
|
|||||||||||||||
Status: | Peer Reviewed | |||||||||||||||
Publication Status: | Published | |||||||||||||||
Reuse Statement (publisher, data, author rights): | © NICE 2018 Technology Appraisal Guidance [TA527] Beta interferons and glatiramer acetate for treating multiple sclerosis. Available from www.nice.org.uk/guidance/ta527. All rights reserved. Subject to Notice of rights (https://www.nice.org.uk/terms-and-conditions#notice-of-rights). NICE guidance is prepared for the National Health Service in England. All NICE guidance is subject to regular review and may be updated or withdrawn. NICE accepts no responsibility for the use of its content in this product/publication. | |||||||||||||||
Access rights to Published version: | Open Access (Creative Commons) | |||||||||||||||
Copyright Holders: | National Institute for Health and Care Excellence (NICE) | |||||||||||||||
Date of first compliant deposit: | 6 August 2018 | |||||||||||||||
Contributors: |
|
Request changes or add full text files to a record
Repository staff actions (login required)
![]() |
View Item |